BackStructure Therapeutics Overview

Structure Therapeutics Accounts Payable

Structure Therapeutics's accounts payable is $7.8M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$7.82M
10.20% YoYΔ $-888000.00 vs prior year quarter

Peer average

Loading

Structure Therapeutics Accounts Payable History

Loading

Structure Therapeutics vs. peers: Accounts Payable Comparison

Loading

Structure Therapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Structure Therapeutics (GPCR) FAQ

As of the most recent data (March 2026), GPCR shows a accounts payable of $7.8M. That compares with $8.7M in the prior-year period — down 10.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GPCR's accounts payable is now $7.8M (was $8.7M) — a 10.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Structure Therapeutics is outperforming or lagging.

Tracking GPCR's accounts payable over time shows whether Structure Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $7.8M That compares with $8.7M in the prior-year period — down 10.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Structure Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $7.8M) with ownership activity and broader fundamentals.